Nutex Health Announces Pricing of $10.0 Million Registered Direct Offering of Common Stock and Warrants
HOUSTON, Jan. 23, 2024 /PRNewswire/ — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), today announced that it has entered into a securities purchase agreement with a single healthcare focused institutional investor whereby the investor has agreed to purchase 66,666,666 shares of common stock and warrants to purchase up to an aggregate of 66,666,666 shares of common stock at a purchase price of $0.15 per share and accompanying warrant in a registered direct offering. The warrants have an exercise price of $0.15 per share, are exercisable immediately, and will expire five years following the date of issuance.
Related news for (NUTX)
- Nutex Health and its Hospitals Earn Record-Breaking 20 Awards and Accolades in Q3
- NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF WESLEY BAMBURG AS ITS NEW CHIEF OPERATING OFFICER
- NUTEX HEALTH PROVIDES FINANCIAL REPORTING UPDATE
- NUTEX HEALTH PROVIDES PRELIMINARY SECOND QUARTER FINANCIAL RESULTS, ANNOUNCES DELAY IN FILING ITS 2025 SECOND QUARTER FINANCIAL STATEMENTS AND ANNOUNCES A STOCK REPURCHASE PROGRAM OF UP TO $25 MILLION
- Nutex Health Schedules 2025 Second Quarter Financial Results Release and Conference Call